Posterior reversible encephalopathy after intrathecal methotrexate therapy in diffuse large B-cell lymphoma

Br J Haematol. 2013 Jun;161(5):607. doi: 10.1111/bjh.12331. Epub 2013 Apr 25.

Authors

Amit Patel^{1

2}, Robert Ayto³, Donald H MacDonald¹

Affiliations

¹ Centre for Haematology & Centre for Perioperative Medicine and Critical Care Research, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, UK.
² MRC Clinical Sciences Centre, Hammersmith Hospital, Imperial College London, London, UK.
³ Department of Haematology, The North West London Hospitals NHS Trust, London, UK.

PMID: 23617825
DOI: 10.1111/bjh.12331

No abstract available

Publication types

Case Reports

MeSH terms

Antimetabolites, Antineoplastic / administration & dosage
Antimetabolites, Antineoplastic / adverse effects*
Antimetabolites, Antineoplastic / therapeutic use
Diffusion Magnetic Resonance Imaging
Female
Humans
Injections, Spinal
Lymphoma, Large B-Cell, Diffuse / drug therapy*
Methotrexate / administration & dosage
Methotrexate / adverse effects*
Methotrexate / therapeutic use
Middle Aged
Posterior Leukoencephalopathy Syndrome / chemically induced*
Posterior Leukoencephalopathy Syndrome / diagnosis

Substances

Antimetabolites, Antineoplastic
Methotrexate